Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Listen to this Section


$5.58
N/A ( 0% ) 41.9K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$5.58

Previous close


$5.58

Volume


41.9K

Market cap


$152.15M

Day range


$5.55 - $5.69

52 week range


$5.26 - $11.92

Insider Ownership Transactions

Total Amount Purchased: -280,438.00 | $ -1,564,844.04

Date Type Amount Purchased Purchaser
2024-03-27 Sale -2114.00 RALLIS CHRIS A
2024-03-27 Sale -13975.00 Andrade Robert
2024-03-25 Sale -13975.00 Andrade Robert
2024-01-05 Sale -15000.00 Andrade Robert
2023-12-29 Sale -8540.00 Raykov Rosty
2023-12-28 Sale -1390.00 RALLIS CHRIS A
2023-11-20 Sale -269.00 RALLIS CHRIS A
2023-11-16 Sale -133333.00 Islam Khalid
2023-11-09 Sale -17049.00 Raykov Rosty
2023-11-03 Sale -74793.00 Raykov Rosty

SEC Fillings


Form Type Description Pages Date
4/a Other 1 Apr 26, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 18, 2024
4 Insider transactions 1 Apr 16, 2024
4 Insider transactions 1 Apr 15, 2024
4 Insider transactions 1 Apr 05, 2024
4 Insider transactions 1 Apr 03, 2024
4 Insider transactions 1 Apr 03, 2024
4 Insider transactions 1 Apr 03, 2024
10-k Annual reports 82 Mar 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.